SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sunu Philip, Armin Kamyab, Paraskevi Orfanou, A Free Terminal Ileal Perforation From Active Crohn Disease in Pregnancy: A Diagnostic Challenge, International Surgery, 2015, 100, 3, 450

    CrossRef

  2. 2
    Licia Maria Henrique da Mota, Bóris Afonso Cruz, Claiton Viegas Brenol, Daniel Feldman Pollak, Geraldo da Rocha Castelar Pinheiro, Ieda Maria Magalhães Laurindo, Ivânio Alves Pereira, Jozélio Freire de Carvalho, Manoel Barros Bertolo, Marcelo de Medeiros Pinheiro, Max Victor Carioca Freitas, Nilzio Antônio da Silva, Paulo Louzada-Júnior, Percival Degrava Sampaio-Barros, Rina Dalva Neubarth Giorgi, Rodrigo Aires Corrêa Lima, Luis Eduardo Coelho Andrade, Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides, Revista Brasileira de Reumatologia (English Edition), 2015, 55, 3, 281

    CrossRef

  3. 3
    Licia Maria Henrique da Mota, Bóris Afonso Cruz, Claiton Viegas Brenol, Daniel Feldman Pollak, Geraldo da Rocha Castelar Pinheiro, Ieda Maria Magalhães Laurindo, Ivânio Alves Pereira, Jozélio Freire de Carvalho, Manoel Barros Bertolo, Marcelo de Medeiros Pinheiro, Max Victor Carioca Freitas, Nilzio Antônio da Silva, Paulo Louzada-Júnior, Percival Degrava Sampaio-Barros, Rina Dalva Neubarth Giorgi, Rodrigo Aires Corrêa Lima, Luis Eduardo Coelho Andrade, Segurança do uso de terapias biológicas para o tratamento de artrite reumatoide e espondiloartrites, Revista Brasileira de Reumatologia, 2015, 55, 3, 281

    CrossRef

  4. 4
    E. Aytac, G. Ozuner, O. Isik, E. Gorgun, F. H. Remzi, Surgical management of patients with ulcerative colitis during pregnancy: Maternal and fetal outcomes, Journal of Crohn's and Colitis, 2015, 9, 1, 82

    CrossRef

  5. 5
    Parambir S. Dulai, Corey A. Siegel, Laurent Peyrin-Biroulet, Anti–Tumor Necrosis Factor-α Monotherapy Versus Combination Therapy with an Immunomodulator in IBD, Gastroenterology Clinics of North America, 2014, 43, 3, 441

    CrossRef

  6. 6
    Jenny T. Woolner, J.O. Hunter, Is dietary treatment of Crohn's disease safe in pregnancy? A retrospective study, e-SPEN Journal, 2014, 9, 5, e173

    CrossRef

  7. 7
    P. Deepak, D. J. Stobaugh, Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2014, 40, 9
  8. 8
    Benjamin Hassid, Uma Mahadevan, The use of biologic therapy in pregnancy, Current Opinion in Rheumatology, 2014, 26, 3, 347

    CrossRef

  9. 9
    Peter Rolny, Morten Vatn, Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article., Scandinavian Journal of Gastroenterology, 2013, 48, 2, 131

    CrossRef

  10. 10
    José Luis Cabriada, Isabel Vera, Eugeni Domènech, Manuel Barreiro-de Acosta, María Esteve, Javier P. Gisbert, Julia Panés, Fernando Gomollón, Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre el uso de fármacos antifactor de necrosis tumoral α en la enfermedad inflamatoria intestinal (2013), Gastroenterología y Hepatología, 2013, 36, 3, 127

    CrossRef

  11. 11
    Javier P Gisbert, María Chaparro, Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease, The American Journal of Gastroenterology, 2013, 108, 9, 1426

    CrossRef

  12. 12
    Laura Marín, Míriam Mañosa, Esther Garcia-Planella, Jordi Gordillo, Yamile Zabana, Eduard Cabré, Eugeni Domènech, Sexual function and patients' perceptions in inflammatory bowel disease: a case–control survey, Journal of Gastroenterology, 2013, 48, 6, 713

    CrossRef

  13. 13
    Olubukola Babalola, Bruce E. Strober, Treatment of atopic dermatitis in pregnancy, Dermatologic Therapy, 2013, 26, 4
  14. 14
    Krisztina Hagymási, Pál Miheller, Zsolt Tulassay, Data for the decrease of “voluntary childlessness” in inflammatory bowel disease, Orvosi Hetilap, 2012, 153, 47, 1855

    CrossRef

  15. 15
    Ole Haagen Nielsen, Tine Jess, IBD: Can TNF inhibitors be administered during the third trimester?, Nature Reviews Gastroenterology & Hepatology, 2012, 10, 3, 130

    CrossRef

  16. 16
    N. K. H. Boer, B. Jharap, M. L. Seinen, A. A. Bodegraven, Letter: thiopurines during pregnancy and intrauterine exposure to metabolites, Alimentary Pharmacology & Therapeutics, 2012, 35, 8
  17. 17
    F. Habal, Letter: thiopurines during pregnancy and intrauterine exposure to metabolites – author's reply, Alimentary Pharmacology & Therapeutics, 2012, 35, 8
  18. You have free access to this content18
    C. P. Selinger, J. Eaden, W. Selby, D. B. Jones, P. Katelaris, G. Chapman, C. McDonald, J. McLaughlin, R. W. L. Leong, S. Lal, Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool (‘CCPKnow’), Alimentary Pharmacology & Therapeutics, 2012, 36, 1
  19. 19
    Luc Biedermann, Gerhard Rogler, Stephan R. Vavricka, Frank Seibold, Mariam Seirafi, Pregnancy and Breastfeeding in Inflammatory Bowel Disease, Digestion, 2012, 86, s1, 45

    CrossRef